Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer

NCT00316420 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Capecitabine (Xeloda)
DRUG: Gemcitabine

Sponsor

Swedish Medical Center

Collaborators

[object Object]